Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial – labiotech (press release) (blog)
labiotech (press release) (blog) |
Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial
labiotech (press release) (blog) GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly improve the vision of patients. But so does the placebo. GenSight Biologics has released the results of a Phase III clinical trial testing its gene … |
